Once breast cancer begins to metastasise, it generally becomes harder to treat and survival rates are lower. Now, researchers present a new, targeted treatment approach using SBRT radiotherapy.
United Imaging debuts its CE-marked uRT-linac 506c at ESTRO 2026 – a CT-linac system with native AI architecture for adaptive radiotherapy workflows.
The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery, new study results find.
The concept of using radiotherapy for osteoarthritis may seem counterintuitive for many clinicians. Yet a well-designed randomised controlled trial presented at the 2025 ASTRO Annual Meeting in San Francisco suggests that low-dose radiotherapy deserves a closer look. The findings add robust evidence to a therapeutic approach that has long been underutilised outside of German-speaking countries.
Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the ledger, a new generation of technologies, from AI-driven adaptive planning to photon-counting CT, that are expanding what the field can do in ways previously unimaginable. At this year’s World Health Expo…
Functional brain radiosurgery is an application of stereotactic radiosurgery (SRS), representing its newest clinical field. It is a precise, non-invasive medical technique using focused ionising radiation to precisely target specific brain structures to modulate brain function for neurological disorders, psychiatric conditions, or intractable pain. The technology offers “precision without…
Radiotherapy is more effective when administered at the right time of day, according to new research. This discovery opens the door to cancer “chronotherapy”, the researchers hope.
Beyond "one-size-fits-all": A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research.
A new study shows a significant survival benefit for patients with oropharyngeal cancers treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).
Researchers have discovered that low physical activity is associated with a higher risk of lymphedema. They have also noted that a lymph scanner objectively measures changes in the condition.
Radiotherapy is effective against prostate cancer but can cause side effects. Using AI, scientists found that images originally taken to help position patients could also predict rectal bleeding.
A novel AI-based method can distinguish between progressive brain tumours and radiotherapy-induced necrosis on advanced MRI. This could help clinicians more accurately identify and treat the issues.
IDH mutated gliomas are slow-growing brain tumors with a relatively good prognosis. A new study shows that many patients reveal measurable cognitive impairment in the first year after treatment.
While saving lives remains the primary goal, a new study explores how radiation therapy also helps breast cancer survivors return to work. Policymakers should factor this in, the researchers argue.
Dunlee will present its portfolio of integrated imaging solutions at RSNA 2025 in Chicago, Illinois. The company will demonstrate technologies for diagnostic and therapeutic imaging applications, including developments in Ultra-High Resolution and Photon Counting CT (UHR & PCCT), components for MRI-guided breast biopsies, and onboard imaging systems for radiation therapy.
Researchers identified a targeted way to protect the brain from harmful side effects of cranial radiation therapy, potentially preserving the quality of life for millions of brain cancer survivors.
Study of 3.7 million children reveals small but significant increased risk of blood cancers from medical imaging radiation, with CT scans posing highest risk
A newly developed method to accurately quantify how much radiation is absorbed by the blood during cancer treatment could lead to more personalised, preventive, and safer radiotherapy.
New research makes a strong case for a new dual-targeting radiopharmaceutical, designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy.
